Thelansis

  Idiopathic pulmonary fibrosis (IPF) is a rare, chronic, progressive fibrosing interstitial pneumonia that affects middle-aged and older adults. It affects lung tissue (alveoli in particular) by either thickening, stiffening or persistent and progressive scarring (fibrosis), which increases irreversibly over time. Scarring damages the air sacs, reducing the amount of oxygen in the blood. With less oxygen in the blood, everyday activities like walking can cause breathlessness. This group of lung disorders is known as ‘Diffuse Parenchymal Lung Diseases’, characterized by a broader umbrella of ‘Interstitial Lung Diseases (IDLs). The progression rate may vary depending on the individual in IPF, characterized by progressive worsening of dyspnea and lung function associated with poor prognosis. IPF comprises a group of lung diseases that damage the lung by unproven causes. However, genetic susceptibility has been found to account for 35 to 40% of cases. Considering no cura...